D-0388-2022 Class III Terminated
FDA drug recall D-0388-2022 was initiated by Dr. Reddy's Laboratories, Inc. on Jan 10, 2022 and is designated Class III. Reason for recall: Subpotent drug The recall status is terminated (terminated Mar 29, 2024). Affected quantity: 18336 cartons.
Recall Details
- Product Type
- Drugs
- Report Date
- Jan 26, 2022
- Initiation Date
- Jan 10, 2022
- Termination Date
- Mar 29, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 18336 cartons
Product Description
Mucus Relief D, Guaifenesin Pseudoephedrine HCl ER Tablets, 600 mg/60mg, packaged in 36-count blister pack packed into cartons, Distributed by: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, Made in India, NDC 0363-164-3
Reason for Recall
Subpotent drug
Distribution Pattern
USA Nationwide
Code Information
Lot #: AT2102065A, AT2102065B, Exp 04/2023.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0388-2022
- openFDA file date
- Oct 26, 2026
- Loaded by RegDataLab
- Oct 27, 2026